Cash on hold, but stem cell work on [California]
By Rebecca Vesely,
Oakland Tribune
| 01. 17. 2006
Agency president vows to push ahead with research despite lawsuits
Beset by legal woes, California's stem cell institute likely won't see voter-approved funds for another 15 months, yet its president said support for scientific research will continue.
"We are not going into hibernation," said Zach Hall, president of the California Institute for Regenerative Medicine. "I am personally determined that we will remain active this year."
In an interview at CIRM's new headquarters in San Francisco overlooking SBC Park, Hall said in 2006 the agency plans to finalize academic and scientific standards, hold several conferences and issue nearly $40 million in training grants announced in the fall.
To do this, and keep administrative operations going, including paying the salaries of 18 staff members, will take a little creative financing, using a combination of loans totalling about $52 million.
As things stand today, the landmark agency that voters in November 2004 overwhelmingly chose to underwrite with $3 billion over 10 years, is set to run out of money June 30.
A lawsuit filed in Alameda County Superior Court bygroups morally opposed toembryonic...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...